Skip to content

Fertility After Prostate Brachytherapy

A Single Site Prospective Descriptive Study on the Effect of Brachytherapy Monotherapy for Prostate Cancer on Male Fertility

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04278443
Enrollment
40
Registered
2020-02-20
Start date
2017-02-24
Completion date
2021-08-05
Last updated
2020-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Brief summary

Although brachytherapy toxicity data on erectile dysfunction, urethral dysfunction and bladder and bowel impact has been collected for a number of years, there is limited information on its effect on male fertility. This study aims to investigate the effect of brachytherapy on fertility

Detailed description

Brachytherapy is a commonly employed technique in the treatment of all prostate cancer risk groups. It delivers a high radiation localised to the prostate gland. The effects of this on fertility have not been systematically studied. An increasing number of younger men for whom fertility is an issue are being diagnosed with prostate cancer and may be offered brachytherapy amongst their treatment choices. This study therefore addresses this issue with a systematic evaluation of sperm count and quality before and after both high dose rate and low dose rate brachytherapy.

Interventions

None listed

Sponsors

BXTAccelyon Ltd
CollaboratorUNKNOWN
East and North Hertfordshire NHS Trust
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum

Inclusion criteria

* Male * 18 years or older * Receiving brachytherapy monotherapy; High or Low dose rate * Ability to ejaculate * Able to provide written informed consent

Exclusion criteria

* History of infertility or vasectomy * Previous chemotherapy or pelvic radiotherapy * Prior use of androgen deprivation therapy * 5 alpha-reductase inhibitors within the last 4 months * Alpha blockers within 7 days of semen collection

Design outcomes

Primary

MeasureTime frameDescription
To define effect of prostate brachytherapy on male fertility.12 monthsmeasure by sequential sperm counts

Countries

United Kingdom

Contacts

Primary ContactPeter Hoskin
peterhoskin@nhs.net0203 826 2438
Backup ContactShreya Armstrong
shreya.armstrong@nhs.net0203 826 2145

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026